Defining the optimal dose of rifapentine for pulmonary tuberculosis: exposure-response relations from two phase II clinical trials - Savic, R M; Weiner, M; MacKenzie, W R (Clin Pharmacol Ther, 2017)
, et al; Tuberculosis Trials Consortium of the Centers for Disease Control and Prevention.